727 related articles for article (PubMed ID: 30981763)
21. Cancer research using organoid technology.
Kretzschmar K
J Mol Med (Berl); 2021 Apr; 99(4):501-515. PubMed ID: 33057820
[TBL] [Abstract][Full Text] [Related]
22. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
Kondo J; Inoue M
Cells; 2019 May; 8(5):. PubMed ID: 31108870
[TBL] [Abstract][Full Text] [Related]
23. Bioengineered Tumor Organoids.
Dominijanni A; Mazzocchi A; Shelkey E; Forsythe S; Devarsetty M; Soker S
Curr Opin Biomed Eng; 2020 Mar; 13():168-173. PubMed ID: 32432209
[TBL] [Abstract][Full Text] [Related]
24. [Normal organoids and their applications in cancer research].
Delom F; Le Morvan V; Robert J; Fessart D
Bull Cancer; 2022 Jan; 109(1):58-64. PubMed ID: 34903368
[TBL] [Abstract][Full Text] [Related]
25. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
[TBL] [Abstract][Full Text] [Related]
26. Next-Generation Modeling of Cancer Using Organoids.
Love JR; Karthaus WR
Cold Spring Harb Perspect Med; 2024 Jun; 14(6):. PubMed ID: 37734867
[TBL] [Abstract][Full Text] [Related]
27. Organoid technology and applications in cancer research.
Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
[TBL] [Abstract][Full Text] [Related]
28. Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment.
Saglam-Metiner P; Gulce-Iz S; Biray-Avci C
Gene; 2019 Feb; 686():203-212. PubMed ID: 30481551
[TBL] [Abstract][Full Text] [Related]
29. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
30. Breakthrough Moments: Organoid Models of Cancer.
Chan AS; Yan HHN; Leung SY
Cell Stem Cell; 2019 Jun; 24(6):839-840. PubMed ID: 31173712
[TBL] [Abstract][Full Text] [Related]
31. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
32. Tumor organoid models in precision medicine and investigating cancer-stromal interactions.
Xu R; Zhou X; Wang S; Trinkle C
Pharmacol Ther; 2021 Feb; 218():107668. PubMed ID: 32853629
[TBL] [Abstract][Full Text] [Related]
33. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
34. [Exploration of organoid in breast cancer related research].
Zheng X; Li J; Sheng J; Zhuo Q; Du Q; Xu Y
Sheng Wu Gong Cheng Xue Bao; 2021 Feb; 37(2):395-403. PubMed ID: 33645143
[TBL] [Abstract][Full Text] [Related]
35. What role could organoids play in the personalization of cancer treatment?
Francies HE; Garnett MJ
Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
[TBL] [Abstract][Full Text] [Related]
36. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
37. Organoid cultures for the analysis of cancer phenotypes.
Sachs N; Clevers H
Curr Opin Genet Dev; 2014 Feb; 24():68-73. PubMed ID: 24657539
[TBL] [Abstract][Full Text] [Related]
38. [Establishment and application of gastric and gastric cancer organoids].
Fan S; Yin J; Wang M; Guan W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1315-1320. PubMed ID: 30506544
[TBL] [Abstract][Full Text] [Related]
39. Emerging organoid models: leaping forward in cancer research.
Fan H; Demirci U; Chen P
J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964
[TBL] [Abstract][Full Text] [Related]
40. Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay.
Costales-Carrera A; Fernández-Barral A; Bustamante-Madrid P; Guerra L; Cantero R; Barbáchano A; Muñoz A
Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31752287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]